Myovant Sciences (MYOV)
Quick facts
| Ticker | MYOV (NYSE (acquired by Sumitomo Pharma)) |
|---|
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: